Xeris Biopharma Holdings
XERS
XERS
91 hedge funds and large institutions have $120M invested in Xeris Biopharma Holdings in 2021 Q4 according to their latest regulatory filings, with 32 funds opening new positions, 33 increasing their positions, 15 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
30% more funds holding
Funds holding: 70 → 91 (+21)
6.56% more ownership
Funds ownership: 26.34% → 32.89% (+6.6%)
Holders
91
Holding in Top 10
2
Calls
$6.72M
Puts
$1.92M
Top Buyers
| 1 | +$18.5M | |
| 2 | +$16.6M | |
| 3 | +$9.52M | |
| 4 |
Lazard Asset Management
New York
|
+$6.83M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$6.27M |
Top Sellers
| 1 | -$8.97M | |
| 2 | -$915K | |
| 3 | -$470K | |
| 4 |
SFI
Susquehanna Fundamental Investments
Bala Cynwyd,
Pennsylvania
|
-$257K |
| 5 |
AGM
Alpine Global Management
New York
|
-$220K |